Related Experiment Video
Updated: Apr 17, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Natural history of growth hormone deficiency in a pediatric cohort
Eva Deillon1, Michael Hauschild, Mohamed Faouzi
1Division of Endocrinology, Diabetology and Obesity, University Hospital Lausanne, Lausanne, Switzerland.
Insights
Many children with growth hormone deficiency (GHD) recover by final height, but complete GHD at diagnosis and low IGF-1 levels predict continued deficiency. Pituitary malformations also indicate persistent GHD.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Deficiency
- Endocrine Disorders
Background:
- Childhood growth hormone deficiency (GHD) evaluation at final height remains controversial.
- Understanding the natural history of GHD in pediatric populations is crucial for accurate diagnosis and management.
- This study investigates the long-term outcomes of GHD in children.
Purpose of the Study:
- To describe the natural history of growth hormone deficiency (GHD) in a pediatric cohort.
- To identify predictors of persistent GHD into adulthood.
- To clarify diagnostic criteria for GHD at the end of growth.
Main Methods:
- Retrospective cohort study of pediatric patients with GHD, excluding acquired cases.
- Univariate and multivariate logistic regression analyses were employed.
- Predictors of GHD persistence into adulthood were identified.
Main Results:
- Of 63 patients, 56% recovered from GHD by final height; 44% remained GH deficient.
- Complete GHD at diagnosis, pituitary stalk defects, increased height gain during treatment, and low IGF-1 levels post-treatment predicted persistence.
- Multivariate analysis confirmed low IGF-1 and complete GHD as significant predictors.
Conclusions:
- A significant proportion (56%) of adolescents with GHD experience recovery by final height.
- Complete GHD at diagnosis, low IGF-1 levels after treatment cessation, and pituitary malformations are key predictors of persistent GHD.
- These findings aid in refining the evaluation and management of pediatric GHD.
Background/Aims:
Controversies still exist regarding the evaluation of growth hormone deficiency (GHD) in childhood at the end of growth. The aim of this study was to describe the natural history of GHD in a pediatric cohort.
Methods:
This is a retrospective study of a cohort of pediatric patients with GHD. Cases of acquired GHD were excluded. Univariate logistic regression was used to identify predictors of GHD persisting into adulthood.
Results:
Among 63 identified patients, 47 (75%) had partial GHD at diagnosis, while 16 (25%) had complete GHD, including 5 with multiple pituitary hormone deficiencies. At final height, 50 patients underwent repeat stimulation testing; 28 (56%) recovered and 22 (44%) remained growth hormone (GH) deficient. Predictors of persisting GHD were: complete GHD at diagnosis (OR 10.1, 95% CI 2.4-42.1), pituitary stalk defect or ectopic pituitary gland on magnetic resonance imaging (OR 6.5, 95% CI 1.1-37.1), greater height gain during GH treatment (OR 1.8, 95% CI 1.0-3.3), and IGF-1 level <-2 standard deviation scores (SDS) following treatment cessation (OR 19.3, 95% CI 3.6-103.1). In the multivariate analysis, only IGF-1 level <-2 SDS (OR 13.3, 95% CI 2.3-77.3) and complete GHD (OR 6.3, 95% CI 1.2-32.8) were associated with the outcome.
Conclusion:
At final height, 56% of adolescents with GHD had recovered. Complete GHD at diagnosis, low IGF-1 levels following retesting, and pituitary malformation were strong predictors of persistence of GHD.
More Related Videos
Related Concept Videos
Nature and Nurture
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Hypoglycemia and Glucagon
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

